CANF logo

Can-Fite BioPharma Ltd. (CANF)

Profile

Full Name

Can-Fite BioPharma Ltd.

Ticker

NYSEAmerican: CANF

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

Israel

IPO

November 6, 2012

Indexes

Not included

Website

http://www.canfite.com

Employees

5

Key Details

Price

$0.70(-28.57%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$674.00K(-9.29% YoY)

Annual EPS

$0.00(+100.00% YoY)

PE ratio

-

Next earnings date

Aug 4, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.70
    CANF price is $0.70

    30-Day Relative Volume

    23.23
    CANF 30-day relative volume is 23.23

    Price Performance

    Price Today change

    -28.57%
    CANF price is down -28.57% today

    Price YTD change

    -57.06%
    CANF price is down -57.06% since January 1st

    Price 1-year change

    -81.13%
    CANF price is down -81.13% year-on-year

    Price 3-year change

    -91.57%
    CANF price is down -91.57% over the past 3 years

    Price Range

    Price All-time high

    $1419.00
    CANF price is currently -99.95% below its historical high of $1419.00

    Price 3-year low

    $0.69
    CANF price is currently +1.35% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $9.00M
    CANF market capitalization is $9.00 million

    Market cap 3-year change

    -60.14%
    CANF market capitalization is down -60.14% over the past 3 years

    Market cap All-time high

    $61.40M
    CANF market capitalization is currently -85.35% below its historical high of $61.40 million

    Market cap sector rank

    15.09%
    CANF market capitalization is higher than 15.09% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +130.66%
    CANF shares outstanding is up +130.66% year-on-year

    Shares Outstanding 3-Year Change

    +372.68%
    CANF shares outstanding is up +372.68% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.59
    CANF beta is 0.59

    200-day SMA

    $1.54
    CANF price is currently -54.47% below its 200-day simple moving average

    50-day SMA

    $1.05
    CANF price is currently -33.60% below its 50-day simple moving average

    RSI

    32.28
    CANF 14-day relative strength index is 32.28

    Volume

    23.23
    CANF 30-day relative volume is 23.23

    ATR

    $0.03
    CANF average true range is $0.03

    10-day Historical Volatility

    23.39%
    CANF 10-day historical volatility is 23.39%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $674.00K
    CANF annual revenue is $674.00 thousand

    Revenue Analysts estimate

    $5.00M
    CANF annual revenue is currently -86.52% lower than the consensus analysts' forecast

    Revenue 1-year change

    -9.29%
    CANF annual revenue is down -9.29% year-on-year

    Revenue Sector rank

    11.54%
    CANF annual revenue is higher than 11.54% of companies in Healthcare sector

    EPS

    EPS

    $0.00
    CANF annual earnings per share is $0.00

    EPS Analysts estimate

    -
    CANF annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +100%
    CANF annual earnings per share is up +100% year-on-year

    EPS Sector rank

    81.33%
    CANF annual earnings per share is higher than 81.33% of companies in Healthcare sector

    Profit

    Gross profit

    -
    CANF annual gross profit value is unknown

    Gross margin

    -
    CANF annual gross profit margin value is unknown

    Operating profit

    -$8.13M
    CANF annual operating income is -$8.13 million

    Operating margin

    -1206.23%
    CANF annual operating profit margin is -1206.23%

    Net income

    -$7.88M
    CANF annual net profit is -$7.88 million

    Net margin

    -1169.14%
    CANF annual net profit margin is -1169.14%

    Expenses

    Total expenses

    $8.80M
    CANF annual total expenses is $8.80 million

    Operating expenses

    $8.80M
    CANF annual total operating expenses is $8.80 million

    Cost of goods sold

    -
    CANF annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $3.05M
    CANF annual SGA is $3.05 million

    Depreciation and amortization

    $7000.00
    CANF annual depreciation & amortization is $7000.00

    Interest expense

    -
    CANF annual interest expense value is unknown

    Income tax

    -
    CANF annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$8.13M
    CANF annual earnings before interest & taxes is -$8.13 million

    EBITDA

    -$8.12M
    CANF annual EBITDA is -$8.12 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $9.12M
    CANF annual total assets is $9.12 million

    Non current assets

    $138.00K
    CANF annual long term assets is $138.00 thousand

    Current assets

    $8.98M
    CANF annual total current assets is $8.98 million

    Cash and cash equivalents

    $4.83M
    CANF annual cash & cash equivalents is $4.83 million

    Accounts receivable

    -
    CANF annual accounts receivable value is unknown

    Inventory

    -
    CANF annual inventory value is unknown

    Liabilities

    Total liabilities

    $3.68M
    CANF annual total liabilities is $3.68 million

    Long term liabilities

    $1.63M
    CANF annual total long term liabilities is $1.63 million

    Current liabilities

    $2.05M
    CANF annual total current liabilities is $2.05 million

    Accounts payable

    $618.00K
    CANF annual accounts payable is $618.00 thousand

    Debt

    Total debt

    $104.00K
    CANF annual total debt is $104.00 thousand

    Total debt 1-year change

    +160%
    CANF annual total debt is up +160% year-on-year

    Long term debt

    $51.00K
    CANF annual long term debt is $51.00 thousand

    Short term debt

    $53.00K
    CANF annual short term debt is $53.00 thousand

    Equity & Capital

    Shareholders equity

    $5.44M
    CANF annual stockholders equity is $5.44 million

    Book value

    $5.44M
    CANF annual book value is $5.44 million

    Retained earnings

    -$166.36M
    CANF annual retained earnings is -$166.36 million

    Working capital

    $6.93M
    CANF annual working capital is $6.93 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$7.64M
    CANF annual cash flow from operations is -$7.64 million

    Cash from operations 1-year change

    +9.51%
    CANF annual cash flow from operations is up +9.51% year-on-year

    Cash from investing

    $1.50M
    CANF annual cash flow from investing activities is $1.50 million

    Cash from investing 1-year change

    +200.2%
    CANF annual cash flow from investing activities is up +200.2% year-on-year

    Cash from financing

    $6.71M
    CANF annual cash flow from financing activities is $6.71 million

    Cash from financing 1-year change

    -26.61%
    CANF annual cash flow from financing activities is down -26.61% year-on-year

    CAPEX

    CAPEX

    $5000.00
    CANF annual capital expenditures is $5000.00

    CAPEX 1-year change

    +150%
    CANF annual capital expenditures is up +150% year-on-year

    Free Cash Flow

    Free cash flow

    -$7.64M
    CANF annual free cash flow is -$7.64 million

    Free cash flow 1-year change

    +9.48%
    CANF annual free cash flow is up +9.48% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CANF annual gross profit margin value is unknown

    Operating margin

    -1206.23%
    CANF annual operating profit margin is -1206.23%

    Net margin

    -1169.14%
    CANF annual net profit margin is -1169.14%

    ROA & ROE

    ROA

    -82.47%
    CANF annual return on assets is -82.47%

    ROE

    -134.94%
    CANF annual return on equity is -134.94%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CANF price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CANF price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.66
    CANF price to book ratio is 1.66

    PB ratio Sector rank

    49.96%
    CANF price to book ratio is higher than 49.96% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CANF price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CANF price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $4.28M
    CANF enterprise value is $4.28 million

    Enterprise value Sector rank

    15.6%
    CANF enterprise value is higher than 15.6% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -
    CANF EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    CANF EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.38
    CANF annual current ratio is 4.38

    Quick ratio

    -
    CANF annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    CANF annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CANF annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CANF piotroski f-score value is unknown

    Altman Z-Score

    -26.03
    CANF altman z-score is -26.03

    Analyst ratings

    Recent major analysts updates

    Apr 15, 25 D. Boral Capital
    Buy
    Mar 21, 25 D. Boral Capital
    Buy
    Mar 20, 25 D. Boral Capital
    Buy
    Mar 18, 25 D. Boral Capital
    Buy
    Mar 3, 25 D. Boral Capital
    Buy
    Feb 18, 25 D. Boral Capital
    Buy
    Dec 31, 24 D. Boral Capital
    Buy
    Dec 5, 24 D. Boral Capital
    Buy
    Nov 12, 24 HC Wainwright & Co.
    Buy
    Jul 17, 24 EF Hutton
    Buy

    Institutional Ownership

    Screeners with CANF included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    Stocks below SMA 200
    Most recommended stocks
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Biotech Companies
    Ex Dividend dates calendar
    Small cap stocks
    • What is the ticker symbol for Can-Fite BioPharma Ltd.?
    • Does Can-Fite BioPharma Ltd. pay dividends?
    • What sector is Can-Fite BioPharma Ltd. in?
    • What industry is Can-Fite BioPharma Ltd. in?
    • What country is Can-Fite BioPharma Ltd. based in?
    • When did Can-Fite BioPharma Ltd. go public?
    • Is Can-Fite BioPharma Ltd. in the S&P 500?
    • Is Can-Fite BioPharma Ltd. in the NASDAQ 100?
    • Is Can-Fite BioPharma Ltd. in the Dow Jones?
    • When was Can-Fite BioPharma Ltd.'s last earnings report?
    • When does Can-Fite BioPharma Ltd. report earnings?

    What is the ticker symbol for Can-Fite BioPharma Ltd.?

    The ticker symbol for Can-Fite BioPharma Ltd. is NYSEAmerican:CANF

    Does Can-Fite BioPharma Ltd. pay dividends?

    No, Can-Fite BioPharma Ltd. does not pay dividends

    What sector is Can-Fite BioPharma Ltd. in?

    Can-Fite BioPharma Ltd. is in the Healthcare sector

    What industry is Can-Fite BioPharma Ltd. in?

    Can-Fite BioPharma Ltd. is in the Biotechnology industry

    What country is Can-Fite BioPharma Ltd. based in?

    Can-Fite BioPharma Ltd. is headquartered in Israel

    When did Can-Fite BioPharma Ltd. go public?

    Can-Fite BioPharma Ltd.'s initial public offering (IPO) was on November 6, 2012

    Is Can-Fite BioPharma Ltd. in the S&P 500?

    No, Can-Fite BioPharma Ltd. is not included in the S&P 500 index

    Is Can-Fite BioPharma Ltd. in the NASDAQ 100?

    No, Can-Fite BioPharma Ltd. is not included in the NASDAQ 100 index

    Is Can-Fite BioPharma Ltd. in the Dow Jones?

    No, Can-Fite BioPharma Ltd. is not included in the Dow Jones index

    When was Can-Fite BioPharma Ltd.'s last earnings report?

    Can-Fite BioPharma Ltd.'s most recent earnings report was on April 14, 2025

    When does Can-Fite BioPharma Ltd. report earnings?

    The next expected earnings date for Can-Fite BioPharma Ltd. is August 4, 2025
    On this page